Elanco Animal Health (ELAN) Common Equity (2017 - 2026)
Elanco Animal Health (ELAN) posted Common Equity of $6.5 billion for Q1 2026, down 0.72% sequentially from $6.5 billion in Q4 2025, and up 2.31% YoY from $6.4 billion in Q1 2025.
Elanco Animal Health (ELAN) Common Equity (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Common Equity for 10 years, with the latest figure at $6.5 billion in Q1 2026.
- Quarterly Common Equity rose 2.31% year-over-year to $6.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 billion (up 2.31% YoY) and the FY2025 annual result came in at $6.5 billion, up 7.4% from the prior year.
- Common Equity fell to $6.5 billion in Q1 2026 per ELAN's latest filing, from $6.5 billion in the prior quarter.
- Over five years, Common Equity peaked at $7.6 billion in Q1 2022 and troughed at $5.9 billion in Q2 2024.
- A 5-year average of $6.7 billion and a median of $6.5 billion in 2025 frame the typical range for Common Equity.
- The sharpest annual moves came in 2024 and 2025: Common Equity fell 19.92% in 2024, then gained 14.02% in 2025.
- Over 5 years, Common Equity stood at $7.3 billion in 2022, then fell by 14.62% to $6.2 billion in 2023, then fell by 2.04% to $6.1 billion in 2024, then increased by 7.4% to $6.5 billion in 2025, then fell by 0.72% to $6.5 billion in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $6.5 billion, $6.5 billion, and $6.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 4.05 Bn |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 1.81 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.59 Bn |
| Mar 31, 2026 | 6.50 Bn |
| Dec 31, 2025 | 6.55 Bn |
| Sep 30, 2025 | 6.75 Bn |
| Jun 30, 2025 | 6.78 Bn |
| Mar 31, 2025 | 6.35 Bn |
| Dec 31, 2024 | 6.10 Bn |
| Sep 30, 2024 | 6.52 Bn |
| Jun 30, 2024 | 5.94 Bn |
| Mar 31, 2024 | 6.06 Bn |
| Dec 31, 2023 | 6.22 Bn |
| Sep 30, 2023 | 6.13 Bn |
| Jun 30, 2023 | 7.42 Bn |
| Mar 31, 2023 | 7.48 Bn |
| Dec 31, 2022 | 7.29 Bn |
| Sep 30, 2022 | 6.71 Bn |
| Jun 30, 2022 | 7.13 Bn |
| Mar 31, 2022 | 7.59 Bn |
| Dec 31, 2021 | 7.51 Bn |
| Sep 30, 2021 | 7.68 Bn |